The 20.5 Data Release provides provides bulk RNAseq data from an age-matched living brain cohort, raw methylation array data from human PHG tissue, and more updates to human studies.
Biochem GWAS | February 23, 2023
In this webinar, speakers Dr. Mariet Allen, Dr. Joseph Reddy, and Stephanie Oatman from the lab of Dr. Nilufer Ertekin-Taner discuss their recent paper Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins, published in Molecular Neurodegeneration (https://doi.org/10.1186/s13024-022-00592-2). View the recording and dataset.
MODEL-AD Workshop at The Jackson Laboratory
MODEL-AD Workshop at The Jackson Laboratory | May 8-12
Sign up for a hands-on immersion workshop focused on Principles and Techniques for Improving Preclinical Translational studies in mouse models for Alzheimer’s Disease at The Jackson Laboratory in Bar Harbor, Maine. This workshop will leverage the expertise and facilities of The Jackson Laboratory, University of Pittsburgh, and Indiana University School of Medicine Model Organism Development for Evaluation of Late Onset Alzheimer’s Disease (MODEL-AD) Precision Medicine consortium. Learn about new mouse models being developed by MODEL-AD and receive hands-on training on techniques necessary for preclinical drug testing. Scholarships are available!
Dr. Melissa Murray contributed bulk RNAseq hippocampus data to the AD Knowledge Portal through the Community Data Contribution Program. The data are part of the Mayo Clinic Hippocampal Vulnerability Study (MayoHippocampus), which provides bulk RNAseq data from the hippocampus of 40 donors with Alzheimer’s disease and 15 nondemented controls from the Mayo Clinic brain bank. Read the full story.